Ascendia

  MARKET NEWS

Saghmos Therapeutics Announces Notice of Allowance for Second US Patent for Phase 3-Ready Cardiorenal Metabolic Modulator
Anima Biotech Announces Preclinical Data of Candidate in Idiopathic Pulmonary Fibrosis
Triumvira Immunologics Announces First Patient Dosed in Phase 1/2 Cell Therapy Trial 
Purolite & Repligen Announce Commercial Launch of Novel CH1 Affinity Resin for the Purification of Specialized mAbs
MiNK Therapeutics' AgenT-797 Shows Promising Results in the Treatment of Severe Acute Respiratory Distress
Dyadic Announces Research & Development Collaboration Agreement With Global Biopharmaceutical Company

  FEATURED EDITORIAL

  COMPANY PROFILE

Oakwood Chemical is a leader in selling high quality reagents to academic, chemical, and pharmaceutical customers for over thirty years. Located in the South Carolina Lowcountry, we have over 10,000 square feet of laboratory space, as well as two large warehouses totaling 200,000 square feet with over 150,000 chemicals in stock. We offer benchtop to production quantities of inorganic and organic reagents, solvents, salts, catalysts, and biochemicals in numerous grades (reagent, anhydrous, ACS, HPLC, LCMS, NMR, USP) and in different amounts (from lab bench to industrial drum sizes). Let us help you in succeeding in this high growth industry. Click here for more.

  EXCLUSIVE ONLINE CONTENT

Abzena Launches LabZient™, an Analytical Platform to Expedite the Path to IND for Antibodies

Abzena Launches LabZient™, an Analytical Platform to Expedite the Path to IND for Antibodies

Abzena recently announced the launch of its new analytical platform, LabZient™. The standardized and automated platform streamlines the assessment and validation of large molecules, which significantly….

CDMO Alcami Expands Fill/Finish Manufacturing Capacity With New Charleston Line

CDMO Alcami Expands Fill/Finish Manufacturing Capacity With New Charleston Line

Alcami Corporation recently announced the strategic expansion of its sterile fill/finish manufacturing capacity with the addition of a new sterile fill/finish line with isolator and two lyophilizers at….

Immix Biopharma Awarded European Union Orphan Drug Designation for NXC-201 in AL Amyloidosis

Immix Biopharma Awarded European Union Orphan Drug Designation for NXC-201 in AL Amyloidosis

Immix Biopharma, Inc. recently announced the European Commission (EC) has granted orphan drug designation to NXC-201 for the treatment of….

FundaMental Pharma GmbH Announces Groundbreaking Proof-of-Concept Study Using a TwinF Interface Inhibitor for the Treatment of Amyotrophic Lateral Sclerosis

FundaMental Pharma GmbH Announces Groundbreaking Proof-of-Concept Study Using a TwinF Interface Inhibitor for the Treatment of Amyotrophic Lateral Sclerosis

FundaMental Pharma GmbH recently announced the publication of a groundbreaking study by Neurobiologists in Heidelberg using FundaMental Pharma’s small molecule TwinF interface inhibitor, FP802…..

  WHITEPAPERS & WEBINARS

WEBINAR - 2024 Trends in Topical Drug Delivery: Insights & Innovation

WEBINAR - 2024 Trends in Topical Drug Delivery: Insights & Innovation

This webinar will discuss some of the key trends from these leaders in the topical market on both a global and regional level, including the increased importance of sensory properties and the rise in non-conventional product formats, among others…..

WEBINAR - Beyond the Lab: Unleashing the Potential of In Silico Modeling in Drug Product Formulation

WEBINAR - Beyond the Lab: Unleashing the Potential of In Silico Modeling in Drug Product Formulation

In this webinar you will learn how digital chemistry tools facilitate rapid screening of formulation parameters, aiding in the identification of optimal drug delivery systems, excipient selection, and dosage forms….

  WHITEPAPERS & WEBINARS

WHITEPAPER - Revolutionizing Small Molecule API Production: Unveiling the Impact of Fermentation as a Sustainable Solution

WHITEPAPER - Revolutionizing Small Molecule API Production: Unveiling the Impact of Fermentation as a Sustainable Solution

While large molecules continue to advance in drug development pipelines, small molecule Active Pharmaceutical Ingredients (APIs) still retain their historical dominance among new drug applications (NDAs). However, the last few years have seen the lines blurring between traditional chemical synthesis …

WHITEPAPER - Minimizing API Supply Chain Risks

WHITEPAPER - Minimizing API Supply Chain Risks

By the time your API is brought to a contract manufacturing organization (CMO), you have already put extensive amounts of resources into developing it. It becomes essential that you optimize your API supply chain to be aware of potential risks

…

WHITEPAPER: Innovating Pharma Barrier Packaging for a Sustainable Future

WHITEPAPER: Innovating Pharma Barrier Packaging for a Sustainable Future

Honeywell Aclar® thermoformable film enables pharmaceutical and medical device companies to achieve their sustainability commitments.

Aclar® film not only delivers a high moisture barrier to protect medicines, but it also reduces pack size, reduces waste, and reduces carbon emissions, compared

…

  DRUG DEVELOPMENT DIRECT RESOURCES

Upcoming eNewsletter Features:

February 21 – ODT/Fast Dissolve
February 28 – Drug Delivery